Art

J-GLOBAL ID：201802221008199748   Reference number：18A1496148

Distinguishing between Individual Direct Oral Anticoagulants on the Basis of their Specific Characteristics

直接経口抗凝固薬(DOAC)の特徴と使い分け

Author (3)： SAKURAI MAMI (日本医科大学付属病院薬剤部) ,  ISE YUYA (日本医科大学付属病院薬剤部) ,  KATAYAMA SHIRO (日本医科大学付属病院薬剤部)
Material： 日本医科大学医学会雑誌
Volume： 14  Issue： 3  Page： 113-120(J-STAGE)  Publication year： 2018 
JST Material Number： L5265A  ISSN： 1349-8975  CODEN： NIDIB3  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： JAPANESE (JA)

Thesaurus term： human(primates) ,...
Semi thesaurus term： vitamin K antagonist ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=18A1496148&from=J-GLOBAL&jstjournalNo=L5265A") }}

Author keywords (4)： direct oral anticoagulants ,  vitamin K antagonist ,  ischemic stroke ,  systemic embolism

JST classification (2)： Drugs acting on circulatory system in general  (GW07010C) ,  Drug therapy(=pharmacotherapy)for cardiovascular system diseases  (GJ05020M)

Substance index (1)： Dabigatran

Reference (21)：

• 1. Tanigawa T, Kaneko M, Hashizume K, et al.: Model-based dose selection for phase III rivaroxaban study in Japanese patients with non-valvular atrial fibrillation. Drug Metab Pharmacokinet 2013; 28: 59-70.
• 2. 家子 正裕: 各種抗凝固薬の特徴とリスク評価. JPN J ELECTROCADIOLOGY 2014; 34: 149-156.
• 3. Almutairi AR, Zhou L, Gellad WF, et al.: Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses. Clin Ther 2017; 39: 1456-1478.
• 4. Connolly SJ, Ezekowitz MD, Yusuf S, et al.: Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009; 361: 1139-1151.
• 5. Reilly PA, Lehr T, Haertter S, et al.: The Effect of Dabigatran Plasma Concentrations and Patient Characteristics on the Frequency of Ischemic Stroke and Major Bleeding in Atrial Fibrillation Patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy). JACC 2014; 63: 321-328.

Terms in the title (2)： 直接経口抗凝固薬 ,  DOAC